Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3
Open Access
- 30 June 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (6), 705-715
- https://doi.org/10.1006/mthe.2002.0606
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cellsOncogene, 2002
- Localization of the Death Domain of Tissue Inhibitor of Metalloproteinase-3 to the N TerminusJournal of Biological Chemistry, 2000
- Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory elementGene Therapy, 2000
- Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53Oncogene, 1999
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Gene Trapping Identifies Inhibitors of Oncogenic TransformationJournal of Biological Chemistry, 1998
- Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4Oncogene, 1997
- Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cellsMatrix Biology, 1996
- Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3Carcinogenesis: Integrative Cancer Research, 1996
- Inhibition of angiogenesis by tissue inhibitor of metalloproteinaseJournal of Cellular Physiology, 1994